Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neglected Tropical Diseases Drugs and Vaccine market report explains the definition, types, applications, major countries, and major players of the Neglected Tropical Diseases Drugs and Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Novartis
Cipla
Romark Laboratories
Sanofi-Aventis
GlaxoSmithKline
Ranbaxy Labs
Macleods Pharmaceuticals
Lupin and Toyama Chemica
Artecef BV
AstraZeneca
By Type:
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
By End-User:
Drugs
Vaccines
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Neglected Tropical Diseases Drugs and Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Neglected Tropical Diseases Drugs and Vaccine Outlook to 2028- Original Forecasts
-
2.2 Neglected Tropical Diseases Drugs and Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Neglected Tropical Diseases Drugs and Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Neglected Tropical Diseases Drugs and Vaccine Market- Recent Developments
-
6.1 Neglected Tropical Diseases Drugs and Vaccine Market News and Developments
-
6.2 Neglected Tropical Diseases Drugs and Vaccine Market Deals Landscape
7 Neglected Tropical Diseases Drugs and Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Neglected Tropical Diseases Drugs and Vaccine Key Raw Materials
-
7.2 Neglected Tropical Diseases Drugs and Vaccine Price Trend of Key Raw Materials
-
7.3 Neglected Tropical Diseases Drugs and Vaccine Key Suppliers of Raw Materials
-
7.4 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate of Raw Materials
-
7.5 Neglected Tropical Diseases Drugs and Vaccine Cost Structure Analysis
-
7.5.1 Neglected Tropical Diseases Drugs and Vaccine Raw Materials Analysis
-
7.5.2 Neglected Tropical Diseases Drugs and Vaccine Labor Cost Analysis
-
7.5.3 Neglected Tropical Diseases Drugs and Vaccine Manufacturing Expenses Analysis
8 Global Neglected Tropical Diseases Drugs and Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Neglected Tropical Diseases Drugs and Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Neglected Tropical Diseases Drugs and Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Malaria Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ebola Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dengue Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Chagas Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Leishmaniasis Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drugs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Vaccines Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.2.2 Canada Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.2 UK Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.3 Spain Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.5 France Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.6 Italy Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.8 Finland Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.9 Norway Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.11 Poland Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.12 Russia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.2 Japan Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.3 India Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.3 Chile Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.6 Peru Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6.3 Oman Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Neglected Tropical Diseases Drugs and Vaccine Consumption (2017-2022)
11 Global Neglected Tropical Diseases Drugs and Vaccine Competitive Analysis
-
11.1 Novartis
-
11.1.1 Novartis Company Details
-
11.1.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.1.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Cipla
-
11.2.1 Cipla Company Details
-
11.2.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.2.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Romark Laboratories
-
11.3.1 Romark Laboratories Company Details
-
11.3.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.3.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi-Aventis
-
11.4.1 Sanofi-Aventis Company Details
-
11.4.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.4.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GlaxoSmithKline
-
11.5.1 GlaxoSmithKline Company Details
-
11.5.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.5.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Ranbaxy Labs
-
11.6.1 Ranbaxy Labs Company Details
-
11.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.6.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Macleods Pharmaceuticals
-
11.7.1 Macleods Pharmaceuticals Company Details
-
11.7.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.7.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Lupin and Toyama Chemica
-
11.8.1 Lupin and Toyama Chemica Company Details
-
11.8.2 Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.8.4 Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Artecef BV
-
11.9.1 Artecef BV Company Details
-
11.9.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.9.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Company Details
-
11.10.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
11.10.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Neglected Tropical Diseases Drugs and Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Ebola Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Dengue Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Chagas Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Neglected Tropical Diseases Drugs and Vaccine
-
Figure of Neglected Tropical Diseases Drugs and Vaccine Picture
-
Table Global Neglected Tropical Diseases Drugs and Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Neglected Tropical Diseases Drugs and Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Malaria Consumption and Growth Rate (2017-2022)
-
Figure Global Ebola Consumption and Growth Rate (2017-2022)
-
Figure Global Dengue Consumption and Growth Rate (2017-2022)
-
Figure Global Chagas Consumption and Growth Rate (2017-2022)
-
Figure Global Leishmaniasis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Table North America Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure United States Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure Germany Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure China Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Neglected Tropical Diseases Drugs and Vaccine Consumption by Country (2017-2022)
-
Figure Australia Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Neglected Tropical Diseases Drugs and Vaccine Consumption and Growth Rate (2017-2022)
-
Table Novartis Company Details
-
Table Novartis Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Cipla Company Details
-
Table Cipla Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Romark Laboratories Company Details
-
Table Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Sanofi-Aventis Company Details
-
Table Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Ranbaxy Labs Company Details
-
Table Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Macleods Pharmaceuticals Company Details
-
Table Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Lupin and Toyama Chemica Company Details
-
Table Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Lupin and Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table Artecef BV Company Details
-
Table Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Artecef BV Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Main Business and Markets Served
-
Table AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
-
Figure Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ebola Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dengue Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chagas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leishmaniasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
